Black women are among those most likely to have insomnia, according to Lynn Rosenberg, ScD, associate director of Boston University’s Slone Epidemiology Center and a principal investigator of the Black Women’s Health Study (BWHS). Rosenberg has been awarded a three-year $2,225,495 grant from the Patient-Centered Outcomes Research Institute (PCORI) to study this. The study will be using a self-administered internet program called SHUTi (Sleep Healthy Using the Internet), a web-tool based on cognitive behavioral therapy (CBT).
CBT is the most effective treatment for insomnia because it treats the underlying causes of the disorder, unlike medications that only treat the symptoms. Unfortunately, there are few healthcare providers in the United States that are trained to provide CBT. There also are other barriers for black women, such as not having adequate access to health care.
While SHUTi has been shown to improve insomnia symptoms, the program has not been tested adequately in black populations. Rosenberg and her team propose to adapt SHUTi to make it more effective for black women and to conduct a study comparing the usual care that most black women will receive if they go to their doctor to seek insomnia treatment (information on sleep hygiene), the standard SHUTi program, and the adapted SHUTi program that has been tailored to black women (SHUTi-BW).
“The SHUTi-BW program, if successful, could improve insomnia symptoms among many black women across the country, which in turn could lower their risk of the many health problems related to poor sleep,” explained Rosenberg.
“This project was selected for PCORI funding not only for its scientific merit and commitment to engaging patients and other stakeholders, but also for its potential to fill an important gap in our health knowledge and give people information to help them weigh the effectiveness of their care options,” said PCORI Executive Director Joe Selby, MD, MPH. “We look forward to following the study’s progress and working with Boston University to share the results.”
Boston University was selected for PCORI funding through a highly competitive review process in which patients, clinicians and other stakeholders joined clinical scientists to evaluate the proposals. Applications were assessed for scientific merit, how well they will engage patients and other stakeholders and their methodological rigor among other criteria.